Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 21, Issue 7, 2009, Pages 851-857

  Abel Ollo, K ^a,b   Rahu, M ^a,c   Rajaleid, K ^d   Talu, A ^a,b   Ruutel K ^a,b,c   Platt, L ^e   Bobrova, N ^f   Rhodes, T ^e   Uuskula A ^b,c  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY OF TARTU   (Estonia)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

HIV; Injecting drug use; Knowledge of HIV serostatus; Risk behaviour; Voluntary counselling and testing

Indexed keywords

FENTANYL;

ADULT; ARTICLE; DIAGNOSTIC TEST; ESTONIA; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VOLUNTARY PROGRAM;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; ESTONIA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 70450175855     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120802657522     Document Type: Article

References (33)

1. Avants, S.K., Warburton, L.A., Hawkins, K.A., & Margolin, A. (2000). Continuation of high-risk behaviour by HIV-positive drug users: Treatment implications. Journal of Substance Abuse Treatment, 19(1), 15-22.
2. Casadonte, P.P., Des Jarlais, D.C., Freiedman, S.R., & Rotrosen, J.P. (1990). Psychological and behavioral impact among intravenousdrug usersof learning HIV test results. The International Journal of the Addictions, 25(4), 409-426.
3. Centers for Disease Control. (1991). Drug use and sexual behaviors among sex partners of injecting-drug users -United States, 1988-1990. MMWR Morbidity Mortality Weekly Report, 13(49), 855-860.
4. Conell, J.A., Parry, J.V., Mortimer, P.P., & Duncan, J. (1993). Novel assay for the detection of immunoglobulin G anti-human immunodeficiency virusin untreated saliva and urine. Journal of Medical Virology, 41(2), 159-164.
5. Crepaz, N., Lyles, C.M., Wolitski, R.J., Passin, W.F., Rama, S.M., Herbst, J.H., et al. (2006). Do prevention interventionsreduce HIV risk behavioursamong people living with HIV? A meta-analytic review of controlled trials. AIDS, 20(2), 143-157.
6. Deren, S., Beardsley, M., Tortu, S., & Goldstein, M.F. (1998). HIV serostatus and changes in risk behaviors among drug injectors and crack users. AIDS and Behavior, 2(2), 171-176.
7. Desenclos, J., Papaevangelou, G., & Ancelle-Park, R. (1993). Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European community study group on HIV in injecting drug users. AIDS, 7(10), 1371-1377.
8. EuroHIV. (2007). HIV/AIDS Surveillance in Europe. Endyear report 2006. Retrieved June 25, 2008, from http://www.eurohiv.org/reports/report-75/pdf/ report-eurohiv-75.pdf
9. Hammersley, R. (1994). A digest of memory phenomena for addiction research. Addiction, 89(3), 283-293.
10. Heckathorn, D.D., Semaan, S., Broadhead, R.S., & Hughes, J.J. (2002). Extensions of respondent-driven sampling: A new approach to the study of injecting drug users aged 18-25. AIDS and Behavior, 6(1), 55-67.
11. Iguchi, M.Y., Donald, A.B., Kushner, H., & Lidz, V. (2001). Correlates of HIV risk among female sex partners of injecting drug users in a high-seroprevalence area. Evaluation and Program Planning, 24, 175-185.
12. Kamb, M.L., Fishbein, M., Douglas, J.M., Rhodes, F., Rogers, J., Bolan, G., et al. (1998). Efficacy of risk reduction counselling to prevent human immunodeficiency virus and sexually transmitted diseases. The Journal of American Medical Association, 280(13), 1161-1168.
13. Klevens, R.M., Fleming, P.L., Neal, J.J., & Li, J. (2001). Knowledge of partner risk and secondary transmission of HIV. American Journal of Preventive Medicine, 20(4), 277-281.
14. Latkin, C.A., & Vlahov, D. (1998). Socially desirable response tendency as a correlate of accuracy of selfreported HIV serostatus for HIV-positive drug users. Addiction, 93(8), 1191-1197.
15. Marks, G., Burris, S., & Peterman, T.A. (1999). Reducing sexual transmission of HIV from those who know they are infected: The need for personal and collective responsibility. AIDS, 13(3), 297-306.
16. McCusker, J., Bigelow, C., Frost, R., Hindin, R., Vickers- Lahti, M., & Zorn, M. (1994). The relationships of HIV status and HIV risky behavior with readiness for treatment. Drug and Alcohol Dependence, 34(2), 129-138.
17. Mertens, T.E., Smith, G.D., & Van Praag, E. (1994). Home Testing for HIV. Lancet, 343(8908), 1293-1295.
18. Parry, J.V., Connell, J.A., Reinbott, P., Garcia, A.B., Avillez, F., & Mortimer, P.P. (1995). GACPAT HIV 1-2: A simple inexpensive assay to screen for, and discriminate between, anti-HIV 1 and anti-HIV 2. Journal of Medical Virology, 45(1), 10-16.
19. Platt, L., Bobrova, N., Rhodes, T., Uusküla, A., Parry, J.V., Rüütel, K., et al. (2006). High HIV prevalence among injecting drug users in Estonia: Implications for understanding the risk environment. AIDS, 20(16), 2120-2123.
20. Rhodes, T., Lowndes, C., Judd, A., Mikhailova, L.A, Sarang, A., Rylkov, A., et al. (2002). Explosive spread and high prevalence of HIV among injecting drug users in Togliatti city, Russia: Implications for HIV prevention. AIDS, 16(13), 25-31.
21. Rhodes, T., & Simic, M. (2005). Transition and the HIV risk environment. BMJ, 331(7510), 220-223.
22. Rhodes, T., Singer, M., Bourgois, P., Friedman, S.R., & Strathdee, S.A. (2005). The social structural production of HIV risk among injecting drug users. Social Science & Medicine, 61(5), 1026-1044.
23. Rhodes, T.J., Donoghoe, M.C., Hunter, G.M., & Stimson, G.V. (1993). Continued risk behaviour among HIVpositive drug injectors in London. Implications for intervention. Addiction, 88(11), 1553-1560.
24. Singh, B.K., Koman, J.J. 3rd., Catan, V.M., Souply, K.L., Birkel, R.C., & Golaszewski, T.J. (1993). Sexual risk behaviour among injection drug-using human immunodeficiency virus positive clients. The International Journal of the Addictions, 28(8), 735-747.
25. Uusküla, A., Heimer, R., Dehovitz, J., Fischer, K., & McNutt, L.A. (2006). Surveillance of HIV, HepatitisB virus, and Hepatitis C virus in an Estonian injection drug-using population: Sensitivity and specificity oftesting syringes for public health surveillance. International Journal of Infectious Diseases, 193(3), 455-457.
26. Uusküla, A., Kals, M., Rajaleid, K., Abel, K., Talu, A., Rüütel, K., et al. (2008). High-prevalence and highestimated incidence of HIV infection among new injecting drug users in Estonia: Need for large scale prevention programs. Journal of Public Health (Oxford, England), 30(2), 119-125.
27. Uusküla, A., McNutt, L.A., Dehovitz, J., Fischer, K., & Heimer, R. (2007). High prevalence of blood-borne virusinfectionsand high-risk behaviour among injecting drug users in Tallinn, Estonia. International Journal of STD & AIDS, 18(1), 41-46.
28. Uusküla, A., Rajaleid, K., Talu, A., Abel, K., Rüütel, K., & Hay, G. (2007). Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addiction Research and Theory, 15(4), 411-424.
29. Deb Hoek, J.A.R., Van Haastrecht, H., & Coutinho, R.A. (1989). Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. American Journal of Public Health, 79(10), 1355-1357.
30. Van Der Perre, P. (2000). HIV voluntary counselling and testing in community health services [commentary]. Lancet, 356(9224), 86-87.
31. Volz, E., Wejnert, C., Degani, I., & Heckathorn, D.D. (2007). Respondent-driven sampling analysis tool (RDSAT) Version 5.6. Ithaca, NY: Cornell University. Retrieved June 16, 2008, from http://www. respondentdrivensampling.org/
32. Wilson, T.E., Sharma, A., Zilmer, K., Kalikova, N., & Uusküla, A. (2007). The HIV prevention needsof injecting drug users in Estonia. International Journal of STD & AIDS, 18(6), 389-391.
33. Wolitski, R.J., MacGowan, R.J., Higgins, D.L., & Jorgensen, C.M. (1997). The effects of HIV counseling and testing and help-seeking behaviour. AIDS Education and Prevention, 9(Suppl. 3), 52-67.